August 20, 2017 12:29 AM ET

Pharmaceuticals

Company Overview of Ritter Pharmaceuticals, Inc.

Audit Committee of Ritter Pharmaceuticals, Inc.

Name (Connections)Board RelationshipsTitleKey Developments
Matthew Foehr 28 RelationshipsDirector
Paul Maier M.B.A.57 RelationshipsDirector
Gerald Proehl 56 RelationshipsDirector

Advisory Committee*

NameBoard RelationshipsTitle Board Affiliations
Roger ClemensMember of Medical Advisory Board25 Relationships
No other board affiliations
Byron CryerMember of Medical Advisory Board32 Relationships
No other board affiliations
Harry GreeneMember of Medical Advisory Board16 Relationships
No other board affiliations
Warren GrundfestMember of Medical Advisory Board47 Relationships
No other board affiliations
Todd KlaenhammerMember of Medical Advisory Board16 Relationships
No other board affiliations
William Sandborn Member of Medical Advisory Board28 Relationships
No other board affiliations
Dennis SavaianoMember of Medical Advisory Board16 Relationships
No other board affiliations
John ShermanMember of Medical Advisory Board16 Relationships
No other board affiliations
W. WalkerMember of Medical Advisory Board16 Relationships
No other board affiliations

Compensation Committee*

Name (Connections)Board RelationshipsTitle
Matthew Foehr 28 RelationshipsDirector
Paul Maier M.B.A.57 RelationshipsDirector
William Merino Ph.D.16 RelationshipsDirector
Ritter Pharmaceuticals, Inc. Compensation vs. Industry
376.3K
423.3K
Chief Executive Officer
Ritter Pharmaceuticals, Inc.
Industry Average

Nominating Committee*

Name (Connections)Board RelationshipsTitleKey Developments
Gerald Proehl 56 RelationshipsDirector
Noah Doyle 66 RelationshipsDirector Ritter Pharmaceuticals, Inc. Appoints William Merino to Board of Directors
William Merino Ph.D.16 RelationshipsDirector

Corporate Governance Committee*

Name (Connections)Board RelationshipsTitle
Noah Doyle 66 RelationshipsDirector
William Merino Ph.D.16 RelationshipsDirector
Gerald Proehl 56 RelationshipsDirector
and Competitor
Insiders vs. External
Board
Ritter Pharmaceuticals, Inc.
18%
82%
There is no Key Competitor Insiders data available
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Active Committee Members by Competitor

SymbolCommittee MemberNumber of Committees
There is no Active Committee Members data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ritter Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.